09/06/2024 6:11 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 6:14 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024 6:17 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024 6:06 PM | Dobek Maria (Reporting) Janux Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 3:20 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 3:28 PM | Janux Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 7:00 PM | Hernday Natasha (Reporting) Janux Therapeutics (Issuer)
| Form 4/A | |
|
07/24/2024 7:00 PM | DOBMEIER ERIC (Reporting) Janux Therapeutics (Issuer)
| Form 4/A | |
07/22/2024 7:01 PM | Hernday Natasha (Reporting) Janux Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/22/2024 7:01 PM | DOBMEIER ERIC (Reporting) Janux Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/22/2024 7:03 PM | Hernday Natasha (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 7:04 PM | DOBMEIER ERIC (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 4:00 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2024 3:30 PM | CAPPS VICKIE L (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) Simson Jake (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Barrett Ronald W (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Gujrathi Sheila (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) Kung Winston (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) McNulty Alana B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:30 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 3:35 PM | Janux Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:19 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:23 PM | Janux Therapeutics (Issuer) Reardon Tighe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:25 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:28 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
06/03/2024 5:58 PM | Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 6:02 PM | Avalon BioVentures I, LP (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 5:48 PM | Avalon BioVentures SPV I, L.P. (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 8:13 AM | Janux Therapeutics (Filer)
| Form S-3ASR | |
05/07/2024 7:05 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:14 PM | Janux Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 3:16 PM | Janux Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024 3:20 PM | Janux Therapeutics (Filer)
| Form DEFA14A | |
03/08/2024 3:47 PM | Janux Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024 3:23 PM | Janux Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 5:54 PM | Janux Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024 3:15 PM | Janux Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:07 PM | Avalon Ventures XI, L.P. (Filed by) Janux Therapeutics (Subject)
| Form SC 13D/A | |
03/04/2024 6:31 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:44 PM | Gujrathi Sheila (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:33 PM | CAPPS VICKIE L (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Ex-CIA Advisor: “This is How Kamala will Rig the Election” (Ad) A former CIA advisor with close ties to the White House…
Has just released this shocking expose on Kamala’s plan to stop Trump.
Every American needs to prepare now…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9380&Placement=NativeDisplay&Source=NativeDisplay) Click here now and learn how to prepare. |
02/29/2024 4:30 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
02/29/2024 4:11 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 8:55 PM | Janux Therapeutics (Subject)
| Form FWP | |
02/28/2024 4:15 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 8:50 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
02/27/2024 4:23 PM | Janux Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:43 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Janux Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 3:31 PM | Campbell David Alan (Filed by) Janux Therapeutics (Subject)
| Form SC 13G/A | |
01/03/2024 3:49 PM | Campbell David Alan (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:50 PM | Janux Therapeutics (Issuer) Meyer Andrew Hollman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:52 PM | Janux Therapeutics (Issuer) Reardon Tighe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:53 PM | Janux Therapeutics (Issuer) Robinson Byron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:54 PM | Janux Therapeutics (Issuer) Winter Charles M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:46 PM | Janux Therapeutics (Issuer) Lichter Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:48 PM | Janux Therapeutics (Issuer) Reardon Tighe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 6:11 PM | Avalon BioVentures I, LP (Reporting) Avalon BioVentures SPV I, L.P. (Reporting) Avalon Ventures XI, L.P. (Reporting) Janux Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:19 PM | Janux Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/07/2023 5:14 PM | Godfrey Wayne (Reporting) Janux Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |